The store will not work correctly when cookies are disabled.
4-methyl-N-(6-(1-methyl-1H-indol-7-yl)pyridazin-3-yl)benzenesulfonamide
ID: ALA4790147
PubChem CID: 147928416
Max Phase: Preclinical
Molecular Formula: C20H18N4O2S
Molecular Weight: 378.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(S(=O)(=O)Nc2ccc(-c3cccc4ccn(C)c34)nn2)cc1
Standard InChI: InChI=1S/C20H18N4O2S/c1-14-6-8-16(9-7-14)27(25,26)23-19-11-10-18(21-22-19)17-5-3-4-15-12-13-24(2)20(15)17/h3-13H,1-2H3,(H,22,23)
Standard InChI Key: IJJQUAPWDFMKME-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
31.2555 -9.4968 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.8510 -8.7910 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
30.4421 -9.4942 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.0225 -8.8033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.0213 -9.6229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7294 -10.0318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4390 -9.6224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4362 -8.7997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7276 -8.3945 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.3152 -10.0312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6075 -9.6203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9000 -10.0277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8989 -10.8457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1424 -8.3885 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.5578 -8.3831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2654 -8.7925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9711 -8.3819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9685 -7.5638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2543 -7.1581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5515 -7.5710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6741 -7.1516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3159 -10.8450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6162 -11.2567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7915 -12.0494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5996 -12.1276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9236 -11.3833 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.7215 -11.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 23 1 0
22 10 1 0
5 10 1 0
8 14 1 0
14 2 1 0
2 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 22 1 0
26 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 378.46 | Molecular Weight (Monoisotopic): 378.1150 | AlogP: 3.74 | #Rotatable Bonds: 4 |
Polar Surface Area: 76.88 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.22 | CX Basic pKa: ┄ | CX LogP: 3.73 | CX LogD: 2.95 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.59 | Np Likeness Score: -1.41 |
References
1. Kimura H,Suda H,Kassai M,Endo M,Deai Y,Yahata M,Miyajima M,Isobe Y. (2021) N-(6-phenylpyridazin-3-yl)benzenesulfonamides as highly potent, brain-permeable, and orally active kynurenine monooxygenase inhibitors., 33 [PMID:33359168] [10.1016/j.bmcl.2020.127753] |